Intelligence · Clinical Pipeline
Neurology & CNS R&D Pipeline
Alzheimer's, Parkinson's, epilepsy, MS, and CNS pipeline assets tracked by phase and sponsor.
- Programs
- 676
Quick answer
Neurology & CNS: NovaPharmaNews indexes 676 neurology & cns clinical pipeline programs from ClinicalTrials.gov with phase, modality, NCT identifiers, and sponsor company links. Alzheimer's, Parkinson's, epilepsy, MS, and CNS pipeline assets tracked by phase and sponsor.
Top sponsors
- HOFFMANN-LA ROCHE 38 programs
- Teva Pharma 37 programs
- Takeda 32 programs
- BRIGHT MINDS BIOSCIENCES 30 programs
- United Therapeutics Europe 26 programs
- Chinese Academy of 24 programs
- Anaxis Pharma 22 programs
- Novartis India 21 programs
- Jazz Pharmaceuticals Ireland 20 programs
- NEUROCRINE BIOSCIENCES 18 programs
- SUPERNUS PHARMACEUTICALS 18 programs
- Acadia Pharmaceuticals 16 programs
-
Rivastigmine
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
Rivastigmine
Atrium Therapeutics
Parkinson's Disease
1 trial -
Rivastigmine transdermal patch
Novartis Pharmaceuticals
Alzheimer's Disease
1 trial -
SULPIRIDE , QUETIAPINE , PERPHENAZINE , CLOTIAPINE , ZIPRASIDONE , HALOPERIDOL , SERTINDOLE , PALIPERIDONE , ZUCLOPENTHIXOL , CARIPRAZINE , LEVOMEPROMAZINE , LURASIDONE , BREXPIPRAZOLE , AMISULPRIDE , CLOZAPINE , CHLORPROMAZINE , RISPERIDONE , FLUPHENAZINE , PROMAZINE , ARIPIPRAZOLE , ASENAPINE , OLANZAPINE , FLUPENTIXOL
Disc Medicine
schizophrenia, schizoaffective disorder, schizophrenifom disorder
1 trial -
Sativex
Jazz Pharmaceuticals Ireland Limited
Multiple Sclerosis
2 trials -
Selective serotonin reuptake inhibitor (SSRI)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Anxiety Depression
1 trial -
Shared Solutions® plus MS Center v. Shared Solutions®
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
Sodium valproate
Chinese University of Hong Kong
Epilepsy
1 trial -
Topiramate
Janssen Cilag International NV
Epilepsy
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis
4 trials -
Valbenazine
NEUROCRINE BIOSCIENCES INC
Schizophrenia
3 trials -
Valproic acid
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
2 trials -
Varenicline
BRIGHT MINDS BIOSCIENCES INC.
Parkinson's Disease
1 trial -
Vortioxetine
Takeda
Schizophrenia
1 trial -
Vortioxetine
Takeda
Unipolar Major Depression
1 trial -
ZULRESSO®
SUPERNUS PHARMACEUTICALS, INC.
Postpartum Depression
1 trial -
Zeposia 0.92 mg hard capsules
Verona Pharma Ireland Limited
Relapsing Multiple Sclerosis (relapsing-remitting, relapsing-progressive)
1 trial -
carbidopa, levodopa, entacapone
Novartis Pharmaceuticals
Parkinson's Disease
1 trial -
diclofenac sodium topical gel
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
glatiramer acetate
Teva Pharma GmbH
Multiple Sclerosis
2 trials -
glatiramer acetate injection with oral cetirizine hydrochloride
Teva Pharma GmbH
Multiple Sclerosis
1 trial -
sodium valproate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Epilepsy
1 trial -
vortioxetine
Takeda
Depression
1 trial -
Azilect
Teva Pharma GmbH
Parkinson's Disease
1 trial -
Blood ponction
MAIA Biotechnology
Alzheimer Blood Biomarkers
1 trial -
Bupivacaine / fentaNYL
Grace Therapeutics
Depression, Postpartum
1 trial -
Chinese herbs
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression
1 trial -
Escitalopram (Oral antidepressant)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Depression - Major Depressive Disorder
1 trial -
Esketamine nasal spray
United Therapeutics Europe Ltd
Depression
1 trial -
Fluoxetine
United Therapeutics Europe Ltd
Depression - Major Depressive Disorder
1 trial -
Fluoxetine
The University of Hong Kong
Depression
1 trial -
Goserelin 3.6 mg implant
Universal Integrated
Postpartum Depression
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Ketogenic Diet
United Therapeutics Europe Ltd
CNS Oxygen Toxicity, Ketogenic Diet
1 trial -
Ketogenic diet
Hospital Authority, Hong Kong
Drug Resistant Epilepsy
1 trial -
MINGO
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
X-Linked Dystonia Parkinsonism
1 trial -
Olanzapine
Guangzhou Psychiatric Hospital
Schizophrenia
1 trial -
Orthica Soft Multi Mini and Orthica Fish EPA Mini
Atrium Therapeutics
Psychiatric Hospitalization
1 trial -
Overnight polysomnography
COGNITION THERAPEUTICS INC
Alzheimer Disease, Early Onset
1 trial -
Rituximab, Methotrexate, and Thiotepa (R-MT) Induction Followed by Etoposide and Cytarabine (EA) Consolidation
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
SSRI treated group
Samsung Bioepis NL B.V.
Depression
2 trials -
Sarcosine
BRIGHT MINDS BIOSCIENCES INC.
Schizophrenia
1 trial -
Sarcosine Capsule
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Parkinson's Disease With Dementia
1 trial -
Standard of Care medication for early Alzheimer's Disease
BRIGHT MINDS BIOSCIENCES INC.
Alzheimer Disease
1 trial -
Targeted Amino Acid Supplement
United Therapeutics Europe Ltd
Parkinson Disease (PD)
1 trial -
Ublituximab
TG THERAPEUTICS, INC.
Multiple Sclerosis (MS) - Relapsing-remitting
1 trial
Frequently asked questions
How many neurology & cns pipeline programs are tracked?
676 programs match this therapeutic area based on indication text, program name, and registry metadata.
Where does pipeline data come from?
ClinicalTrials.gov records linked to NovaPharmaNews company profiles. Verify on ClinicalTrials.gov before investment decisions.
Data attribution: Data sources · All pipeline programs